We could not find any results for:
Make sure your spelling is correct or try broadening your search.
YOKNEAM, ISRAEL and WAYLAND, MA -- (Marketwire) -- 01/05/10 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical...
Candela Corporation (NASDAQ:CLZR) today reported that revenues for the quarter ended September 26, 2009 were $26.2 million. Net loss for the quarter was $3,627,000 or $0.16 per...
Candela Corporation (NASDAQ: CLZR) will report financial results for its first quarter on Tuesday, October 20, 2009 at approximately 4:05 p.m. (EDT), after the market closes...
Attorney Advertising. Notice is hereby given that a class action has been commenced on behalf of shareholders of Candela Corporation (“Candela” or the “Company”) (Nasdaq: CLZR...
Syneron Medical Ltd. (NASDAQ:ELOS) and Candela Corporation (NASDAQ:CLZR) announced today that they have entered into a definitive agreement to combine the companies in an all...
Candela Corporation (NASDAQ:CLZR) today reported that revenues for the quarter ended June 27, 2009 were $31.4 million. Income from continuing operations, including non-cash...
Candela Corporation (NASDAQ: CLZR) will report financial results for its fourth quarter and fiscal year-end on Tuesday, August 18, 2009 at approximately 4:05 p.m. (EDT), after...
Candela Corporation (NASDAQ:CLZR) today announced that it has received registration approval from the Brazilian National Health Surveillance Agency (ANVISA) to market the...
Candela Corporation (NASDAQ:CLZR) today announced that it has received registration approval from the Brazilian National Health Surveillance Agency (ANVISA) to market the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions